ArticleJournal of clinical medicine2025
Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months.
Agustín Sancho-Saldaña, Anna Gil-Sánchez, Bibiana Quirant-Sánchez, Marc Boigues, Marc Canudes, Silvia Peralta, María José Solana, Cristina González-Mingot, Laura Quibus, Eva Martínez-Cáceres and 4 more
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Agustín Sancho-SaldañaServicio de Neurología, Hospital Universitario Arnau de Vilanova, 25198 Lleida, Spain.
Anna Gil-SánchezServicio de Neuroinmunología, Institut de Recerca Biomèdica de Lleida-IRBLleida, 25198 Lleida, Spain.ORCID 0000-0002-0738-5578 Bibiana Quirant-SánchezImmunology Division, Germans Trias i Pujol University Hospital and Research Institute, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Marc BoiguesImmunology Division, Germans Trias i Pujol University Hospital and Research Institute, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Marc CanudesServicio de Neuroinmunología, Institut de Recerca Biomèdica de Lleida-IRBLleida, 25198 Lleida, Spain.
Silvia PeraltaServicio de Neurología, Hospital Universitario Arnau de Vilanova, 25198 Lleida, Spain.
María José SolanaServicio de Neurología, Hospital Universitario Arnau de Vilanova, 25198 Lleida, Spain.
Cristina González-MingotServicio de Neurología, Hospital Universitario Arnau de Vilanova, 25198 Lleida, Spain.ORCID 0000-0002-6387-8764 Laura QuibusServicio de Neuroinmunología, Institut de Recerca Biomèdica de Lleida-IRBLleida, 25198 Lleida, Spain.
Eva Martínez-CáceresImmunology Division, Germans Trias i Pujol University Hospital and Research Institute, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
Pascual TorresServicio de Neuroinmunología, Institut de Recerca Biomèdica de Lleida-IRBLleida, 25198 Lleida, Spain.ORCID 0000-0001-7903-3478 José Vicente HervásServicio de Neurología, Hospital de Sant Joan Despí Moisés Broggi, 08970 Barcelona, Spain.
Judith Moreno-MagallonServicio de Neuroinmunología, Institut de Recerca Biomèdica de Lleida-IRBLleida, 25198 Lleida, Spain.ORCID 0009-0006-6394-3323 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cytokinesdisease-modifying therapiesIL-18multiple sclerosisSARS-CoV-2seropositivity
Identifiers
PMID40507498
PMCPMC12155705
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390